Contrast-enhanced ultrasound of hepatocellular carcinoma: Where do we stand?

Risultato della ricerca: Articlepeer review

14 Citazioni (Scopus)


Contrast-enhanced ultrasound (CEUS) represents a significant breakthrough in ultrasonography (US), and it is being increasingly used for the evaluation of focal liver lesions (FLLs). CEUS is unique in that it allows non-invasive assessment of liver perfusion in real time throughout the vascular phase, which has led to dramatic improvements in the diagnostic accuracy of US in the detection and characterization of FLLs, the choice of therapeutic procedures, and the evaluation of response. Currently, CEUS is included as a part of the suggested diagnostic work-up of FLLs, including in cirrhotic patients with hepatocellular carcinoma, resulting in better patient management and cost-effective delivery of therapy.
Lingua originaleEnglish
pagine (da-a)200-214
Numero di pagine15
Stato di pubblicazionePublished - 2019

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2741???


Entra nei temi di ricerca di 'Contrast-enhanced ultrasound of hepatocellular carcinoma: Where do we stand?'. Insieme formano una fingerprint unica.

Cita questo